Poly Medicure dropped 7.07% to Rs 2939, following a sharp rally in the past three sessions.
The stock soared 23.16% in the past three sessions, driven by strong Q2FY25 results announced on Tuesday (29 October 2024).On a consolidated basis, net profit of Poly Medicure rose 40.62% to Rs 87.45 crore on 24.53% increase in net sales to Rs 420.02 crore in Q2 September 2024 over Q2 September 2023.
Profit before tax stood at Rs 117.98 crore in the Q1 FY25, up 45.7% YoY and up 19.83% QoQ. Operating profit margin (OPM) expanded to 27% in Q2 FY25, up from 25% in the same period last year.
Poly Medicure manufactures disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app